NS11821, a partial subtype-selective GABAA agonist, elicits selective effects on the central nervous system in randomized controlled trial with healthy subjects
Zuiker, Rob G J A, Chen, Xia, Østerberg, Ole, Mirza, Naheed R, Muglia, Pierandrea, de Kam, Marieke, Klaassen, Erica S, van Gerven, Joop M A
Published in Journal of psychopharmacology (Oxford) (01.03.2016)
Published in Journal of psychopharmacology (Oxford) (01.03.2016)
Get more information
Journal Article
High treatment adherence, satisfaction, motivation, and health-related quality of life with fingolimod in patients with relapsing-remitting multiple sclerosis - results from a 24-month, multicenter, open-label Danish study
Schreiber, Karen, Kant, Matthias, Pfleger, Claudia, Jensen, Henrik Boye, Oesterberg, Ole, Hald, Anne Rieper, Nielsen, Frederik K, Rubak, Sune
Published in Patient preference and adherence (01.01.2018)
Published in Patient preference and adherence (01.01.2018)
Get full text
Journal Article